Blog
Follow us for the latest trends, insights and innovations in the pharmaceutical industry.
Hydrogenation in Pharmaceutical Intermediates: Risks and Solutions
This article breaks down 4 core risks with authoritative industry data, and shares full-process, FDA & ICH-aligned solutions to reduce accidents, improve yields and ensure ...
Read More →
Technology Transfer Pitfalls in Intermediate Projects: Avoid Costly Mistakes
This article breaks down the 4 most costly mistakes — including incomplete documentation and ignored scalability — with verified industry data and real cases.
Read More →
A Comprehensive Supply Chain for Core Intermediates in Diabetes Treatment
End-to-end supply chain for anti-diabetic intermediates. Covering DPP-4, SGLT-2 inhibitors & GPR40 agonists. Stable, compliant, scalable.
Read More →
CDMO vs. Direct Manufacturer: Which Model Fits Your API Strategy?
Drawing from on-the-ground experience in China's top pharma clusters, this guide cuts through the jargon to reveal when to partner for complex innovation and when ...
Read More →